Quick Answer
Protagonist Therapeutics, Inc reported Net Income of -$130.15 million for fiscal year 2025.
Protagonist Therapeutics, Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$130.15M | -147.3% |
| 2024 | $275.19M | +448.5% |
| 2023 | -$78.95M | +38.0% |
| 2022 | -$127.39M | -1.5% |
| 2021 | -$125.55M | -89.8% |
| 2020 | -$66.15M | +14.3% |
| 2019 | -$77.19M | -98.3% |
| 2018 | -$38.92M | -5.3% |
| 2017 | -$36.96M | +0.6% |
| 2016 | -$37.18M | -150.2% |
| 2015 | -$14.86M | -34.2% |
| 2014 | -$11.07M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$39.34M | -18.5% | -13.1% |
| June 30, 2025 | -$34.77M | -13.6% | -198.3% |
| March 31, 2025 | -$11.65M | -105.6% | +64.9% |
| September 30, 2024 | -$33.21M | +2.6% | -8.5% |
| June 30, 2024 | -$30.62M | +20.4% | -114.8% |
| March 31, 2024 | $207.34M | +714.8% | +707.9% |
| September 30, 2023 | -$34.10M | -9.2% | +11.3% |
| June 30, 2023 | -$38.46M | +6.3% | -14.0% |
- Protagonist Therapeutics, Inc showed a decrease of -147.3% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Protagonist Therapeutics, Inc’s net income has declined by 1075.5% (from -$11.07 million to -$130.15 million).
- The most recent figure is from Protagonist Therapeutics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: